Literature DB >> 6176223

Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.

G Gregoriadis, A Meehan.   

Abstract

Human blood lymphocytes were coated with increasing amounts of human kappa chain (2-85mug/10(7) cells) through the linking reagent CrCl(3). These cells were then exposed to small unilamellar liposomes composed of egg phosphatidylcholine, cholesterol and phosphatidic acid (molar proportions 7:7:1) containing carboxyfluorescein and/or (111)In-labelled bleomycin and bearing (131)I-labelled affinity chromatography-purified or non-purified anti-(kappa-chain) immunoglobulin G (IgG) [see the preceding paper, Gregoriadis, Meehan & Mah (1981) Biochem. J.200, 203-210]. In some experiments liposomes contained [(14)C]phosphatidylcholine. (1) Lymphocytes (10(7)) coated with 2-85mug of kappa chain and exposed to liposomes devoid of IgG or bearing non-purified anti-(kappa chain) IgG bound only a small proportion of the liposomal markers. Even with liposomes bearing the purified anti-(kappa chain) IgG, uptake of the labels improved only slightly for cells coated with up to 10mug of kappa chain. However, with higher concentrations of the antigen on the cell surface, binding was improved considerably to reach values of 31% ((111)In-labelled bleomycin) and 43% ((131)I-labelled IgG) of added liposomes for cells coated with 85mug of kappa chain. (2) Lymphocytes coated with kappa chain were exposed to liposomes bearing increasing amounts (0-180mug/0.9mg of egg phosphatidylcholine) of purified anti-(kappa chain) IgG. It was found that under the present conditions, binding of all three markers ((111)In-labelled bleomycin, (131)I-labelled IgG and [(14)C]phosphatidylcholine) was directly proportional to the concentration of IgG on the liposomal surface. However, uptake values remained unchanged above 90mug of IgG. (3) Antibody-mediated uptake of liposomes by cells coated with the corresponding antigen without loss of their metabolic activities may provide a method of efficient targeting.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6176223      PMCID: PMC1163526          DOI: 10.1042/bj2000211

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

Review 1.  Interactions of liposomes with mammalian cells.

Authors:  R E Pagano; J N Weinstein
Journal:  Annu Rev Biophys Bioeng       Date:  1978

2.  Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.

Authors:  G Gregoriadis; D E Neerunjun
Journal:  Eur J Biochem       Date:  1974-08-15

3.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

4.  Targeting of drugs: implications in medicine.

Authors:  G Gregoriadis
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

5.  Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues.

Authors:  G Gregoriadis; D E Neerunjun; R Hunt
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

6.  The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro.

Authors:  C Kirby; G Gregoriadis
Journal:  Life Sci       Date:  1980-12-08       Impact factor: 5.037

7.  Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A.

Authors:  L D Leserman; J Barbet; F Kourilsky; J N Weinstein
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

8.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

Authors:  C Kirby; J Clarke; G Gregoriadis
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

9.  Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells.

Authors:  L D Leserman; J N Weinstein; R Blumenthal; W D Terry
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.

Authors:  G Gregoriadis; A Meehan; M M Mah
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

View more
  5 in total

Review 1.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

2.  Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.

Authors:  G Gregoriadis
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

3.  Novel fluorescence method to visualize antibody-dependent hydrogen peroxide-associated "killing" of liposomes by phagocytes.

Authors:  H R Petty; J W Francis
Journal:  Biophys J       Date:  1985-06       Impact factor: 4.033

4.  Novel fluorescence method to visualize antibody-dependent hydrogen peroxide-associated "killing" of liposomes by phagocytes.

Authors:  H R Petty; J W Francis
Journal:  Biophys J       Date:  1985-05       Impact factor: 4.033

5.  Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.

Authors:  G Gregoriadis; A Meehan; M M Mah
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.